Literature DB >> 11278319

Vascular endothelial growth factor receptor-1 and neuropilin-2 form complexes.

Z Gluzman-Poltorak1, T Cohen, M Shibuya, G Neufeld.   

Abstract

The products of the neuropilin-1 (Np-1) and neuropilin-2 (Np-2) genes are receptors for factors belonging to the class 3 semaphorin family and participate in the guidance of growing axons to their targets. In the presence of heparin-like molecules, both receptors also function as receptors for the heparin-binding 165-amino acid isoform of vascular endothelial growth factor (VEGF(165)). Both receptors are unable to bind to the 121-amino acid isoform of vascular endothelial growth factor (VEGF(121)), which lacks a heparin-binding domain. Interestingly, complexes corresponding in size to (125)I-VEGF(121).neuropilin complexes are formed when (125)I-VEGF(121) is bound and cross-linked to porcine aortic endothelial cells co-expressing VEGFR-1 and either Np-1 or Np-2. These complexes do not seem to represent complexes of (125)I-VEGF(121) with a truncated form of VEGFR-1, presumably formed as a result of the presence of Np-1 or Np-2 in the cells, because such truncated forms could not be detected with anti-VEGFR-1 antibodies. Antibodies directed against VEGFR-1 co-immunoprecipitated the (125)I-VEGF(121).Np-2 sized cross-linked complex along with (125)I-VEGF(121).VEGFR-1 complexes from cells expressing both VEGFR-1 and Np-2 but not from control cells, indicating that VEGFR-1 and Np-2 associate with each other. To perform the reciprocal experiment we have expressed in porcine aortic endothelial cells a Np-2 receptor containing an in-frame myc epitope at the C terminus. Surprisingly, the myc-tagged Np-2 receptor lost most of its VEGF(165) binding capacity but not its semaphorin-3F binding ability. Nevertheless, when Np-2myc was co-expressed in cells with VEGFR-1, it partially regained its VEGF(165) binding ability. Antibodies directed against the myc epitope co-immunoprecipitated (125)I-VEGF(165).Np-2myc and (125)I- VEGF(165).VEGFR-1 complexes from cells co-expressing VEGFR-1 and Np-2myc, indicating again that VEGFR-1 associates with Np-2. Our experiments therefore indicate that Np-2, and possibly also Np-1, associate with VEGFR-1 and that such complexes may be part of a cell membrane-associated signaling complex.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11278319     DOI: 10.1074/jbc.M006909200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

Review 1.  Molecular control of arterial-venous blood vessel identity.

Authors:  Ralf H Adams
Journal:  J Anat       Date:  2003-01       Impact factor: 2.610

Review 2.  To move or not to move? Semaphorin signalling in cell migration.

Authors:  Luca Tamagnone; Paolo M Comoglio
Journal:  EMBO Rep       Date:  2004-04       Impact factor: 8.807

Review 3.  Signal transduction by vascular endothelial growth factor receptors.

Authors:  Sina Koch; Lena Claesson-Welsh
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

4.  Neuropilin-1 mediates myeloid cell chemoattraction and influences retinal neuroimmune crosstalk.

Authors:  Agnieszka Dejda; Gaelle Mawambo; Agustin Cerani; Khalil Miloudi; Zhuo Shao; Jean-Francois Daudelin; Salix Boulet; Malika Oubaha; Felix Beaudoin; Naoufal Akla; Sullivan Henriques; Catherine Menard; Andreas Stahl; Jean-Sébastien Delisle; Flavio A Rezende; Nathalie Labrecque; Przemyslaw Sapieha
Journal:  J Clin Invest       Date:  2014-10-01       Impact factor: 14.808

5.  Deficiency of neuropilin 2 suppresses VEGF-induced retinal neovascularization.

Authors:  Jikui Shen; Rebecca Samul; Joelle Zimmer; Hansheng Liu; Xiaoling Liang; Sean Hackett; Peter A Campochiaro
Journal:  Mol Med       Date:  2004 Jan-Jun       Impact factor: 6.354

6.  Structural studies of neuropilin/antibody complexes provide insights into semaphorin and VEGF binding.

Authors:  Brent A Appleton; Ping Wu; Janice Maloney; JianPing Yin; Wei-Ching Liang; Scott Stawicki; Kyle Mortara; Krista K Bowman; J Michael Elliott; William Desmarais; J Fernando Bazan; Anil Bagri; Marc Tessier-Lavigne; Alexander W Koch; Yan Wu; Ryan J Watts; Christian Wiesmann
Journal:  EMBO J       Date:  2007-11-08       Impact factor: 11.598

7.  VEGF in the lung: a role for novel isoforms.

Authors:  Julia Varet; Samantha K Douglas; Laura Gilmartin; Andrew R L Medford; David O Bates; Steven J Harper; Ann B Millar
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-03-12       Impact factor: 5.464

8.  Endorepellin laminin-like globular 1/2 domains bind Ig3-5 of vascular endothelial growth factor (VEGF) receptor 2 and block pro-angiogenic signaling by VEGFA in endothelial cells.

Authors:  Chris D Willis; Chiara Poluzzi; Maurizio Mongiat; Renato V Iozzo
Journal:  FEBS J       Date:  2013-02-28       Impact factor: 5.542

Review 9.  Semaphorins and their receptors in lung cancer.

Authors:  Vincent A Potiron; Joëlle Roche; Harry A Drabkin
Journal:  Cancer Lett       Date:  2008-07-14       Impact factor: 8.679

10.  Differential expression of vascular endothelial growth factor (VEGF), endocrine gland derived-VEGF, and VEGF receptors in human placentas from normal and preeclamptic pregnancies.

Authors:  Jin-Young Chung; Yang Song; Yuping Wang; Ronald R Magness; Jing Zheng
Journal:  J Clin Endocrinol Metab       Date:  2004-05       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.